While the Lakers hope to empty their infirmary to achieve a big end to the season, the franchise has just received very bad news about Kendrick Nunn. The leader has hardly played until now, and we will still have to be patient.
For the Lakers, the next few weeks will be decisive for the playoffs. Getting there shouldn’t be a problem, especially with the return of Anthony Davis, but winning the title will be another story. For many fans, trades are inevitable in order to reverse the trend.
Rob Pelinka, in charge of putting it all in place, seems to agree enough. He has already 6 players to trade by February deadline, but without guarantee of finding a buyer. In addition, he has just learned very bad news on Monday, with a galley that continues for Kendrick Nunn.
A player extends his stay in the infirmary at the Lakers
The leader, who arrived last summer, has still not played a game this season. A real blow for everyone, and which is not going to get better in the coming weeks. Frank Vogel revealed to reporters that the former Heat has had a relapse, and won’t be playing for a while.
Vogel said that Kendrick Nunn’s knee didn’t respond well to increased workouts of late, and said his debut this season will be delayed as a result.
— Mike Trudell (@LakersReporter) January 18, 2022
Vogel says Kendrick Nunn’s knee hasn’t responded well to increased training recently, and explains that his debut this season will be delayed as a result.
For Nunn, we imagine that the situation is not easy, he who would like to help his team in this second part of the season. Unfortunately, he will have to wait, and hope that this relapse is not too serious. A few weeks delay? This may be the best case scenario for him.
The Lakers will have to wake up in the coming weeks, like Russell Westbrook, much criticized for his game. He also challenged his teammates recently, in the hope of a quick reaction.
To witness Kendrick Nunn’s debut this season, the Angelinos will have to wait. Bad news for the player and his team, who may call this partnership into question. We’ll know more by the deadline.
